(Q35569083)

8 August 2017

1 reference

title

Mass drug treatment for lymphatic filariasis and onchocerciasis (English)

1 reference

8 August 2017

0 references

0 references

3

Achim Hoerauf

1 reference

8 August 2017

5

Mark J. Taylor

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14580963

25 March 2024

author name string

Mark Bradley

2

1 reference

8 August 2017

Dominique Kyelem

4

1 reference

8 August 2017

David H. Molyneux

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14580963

25 March 2024

language of work or name

1 reference

1 November 2003

1 reference

full work available at URL

8 August 2017

https://api.elsevier.com/content/article/PII:S1471492203002459?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.004

https://api.elsevier.com/content/article/PII:S1471492203002459?httpAccept=text/plain

25 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.004

25 March 2024

published in

Trends in Parasitology

1 reference

8 August 2017

19

1 reference

8 August 2017

516-522

1 reference

8 August 2017

11

1 reference

Control of onchocerciasis today: status and challenges.

8 August 2017

2

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.004

Partnership and promise: evolution of the African river-blindness campaigns

25 March 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.004

Strategies and tools for the control/elimination of lymphatic filariasis

25 March 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.004

Lymphatic filariasis elimination: progress in global programme development

25 March 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.004

Current status and future prospects of the Global Lymphatic Filariasis Programme

25 March 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.004

Programmatic goals and approaches to onchocerciasis

25 March 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.004

Onchocerciasis control strategies

25 March 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.004

Effects of standard and high doses of ivermectin on adult worms of Onchocerca volvulus: a randomised controlled trial.

25 March 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.004

Ten years of NGDO action against river blindness

25 March 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.004

Impact of ivermectin on onchocerciasis transmission: assessing the empirical evidence that repeated ivermectin mass treatments may lead to elimination/eradication in West-Africa

25 March 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.004

The use of spatial analysis in mapping the distribution of bancroftian filariasis in four West African countries

25 March 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.004

Treatment failure of a single high dose of ivermectin for Mansonella perstans filariasis

25 March 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.004

Efficacy of repeated doses of ivermectin against Mansonella perstans.

25 March 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.004

Final report of the Conference on the eradicability of Onchocerciasis

25 March 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.004

Can ivermectin mass treatments eliminate onchocerciasis in Africa?

25 March 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.004

Antiparasitic properties of medicinal plants and other naturally occurring products

25 March 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.004

Onchocerca ochengi infections in cattle as a model for human onchocerciasis: recent developments.

25 March 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.004

Chemoprophylaxis of Onchocerca infections: in a controlled, prospective study ivermectin prevents calves becoming infected with O. ochengi.

25 March 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.004

A new approach to the treatment of filariasis

25 March 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.004

Antibiotics and Wolbachia in filarial nematodes: antifilarial activity of rifampicin, oxytetracycline and chloramphenicol against Onchocerca gutturosa, Onchocerca lienalis and Brugia pahangi

25 March 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.004

Endosymbiotic bacteria in worms as targets for a novel chemotherapy in filariasis

25 March 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.004

Depletion of wolbachia endobacteria in Onchocerca volvulus by doxycycline and microfilaridermia after ivermectin treatment

25 March 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.004

Doxycycline in the treatment of human onchocerciasis: Kinetics of Wolbachia endobacteria reduction and of inhibition of embryogenesis in female Onchocerca worms

25 March 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.004

Inflammatory responses induced by the filarial nematode Brugia malayi are mediated by lipopolysaccharide-like activity from endosymbiotic Wolbachia bacteria

25 March 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.004

Severe reactions to filarial chemotherapy and release of Wolbachia endosymbionts into blood.

25 March 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.004

Bacterial endosymbionts of Onchocerca volvulus in the pathogenesis of posttreatment reactions

25 March 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.004

Mapping of lymphatic filariasis in Nepal

25 March 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.004

Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection.

25 March 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.004

Effect of a single dose (600 mg) of albendazole on Loa loa microfilaraemia

25 March 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.004

Effects of a 3-day regimen of albendazole (800 mg daily) on Loa loa microfilaraemia

25 March 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.004

Satellite mapping of Loa loa prevalence in relation to ivermectin use in west and central Africa

25 March 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.004

Evidence against Wolbachia symbiosis in Loa loa

25 March 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.004

Obligatory symbiotic Wolbachia endobacteria are absent from Loa loa

25 March 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.004

Ivermectin and albendazole alone and in combination for the treatment of lymphatic filariasis in Ghana: Follow-up after re-treatment with the combination

25 March 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.004

Is wuchereriasis a disappearing disease in Suriname?

25 March 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.004

A successful control programme for lymphatic filariasis in Hubei, China

25 March 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.004

Mass treatment to eliminate filariasis in Papua New Guinea

25 March 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.004

Diethylcarbamazine salt in the control of lymphatic filariasis.

25 March 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.004

Albendazole: a review of anthelmintic efficacy and safety in humans

25 March 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.004

Tolerability and efficacy of single dose albendazole, diethylcarbamazine citrate (DEC) or co-administration of albendazole with DEC in the clearance of Wuchereria bancrofti in asymptomatic microfilaraemic volunteers in Pondicherry, South India: a ho

25 March 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.004

Assessing the risk of benzimidazole therapy during pregnancy

25 March 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.004

The pharmacokinetics, safety and tolerability of the co-administration of diethylcarbamazine and albendazole

25 March 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.004

Clinical picture and outcome of Serious Adverse Events in the treatment of Onchocerciasis

25 March 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.004

Immunocompetence may be important in the effectiveness of Mectizan (ivermectin) in the treatment of human onchocerciasis

25 March 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.004

The impact of 34 years of massive DEC chemotherapy on Wuchereria bancrofti infection and transmission: the Maupiti cohort

25 March 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.004

Identification and stage-specific expression of two putative P-glycoprotein coding genes in Onchocerca volvulus.

25 March 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.004

25 March 2024

Identifiers

1 reference

8 August 2017

1 reference